Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms
暂无分享,去创建一个
John S Witte | Donglei Hu | Thomas J Hoffmann | Elad Ziv | Rajdeep Das | J. Witte | E. Ziv | F. Feng | S. K. Van Den Eeden | D. Hu | T. Hoffmann | R. Das | Joshua D Hoffman | Felix Y Feng | J. Shan | Stephen K Van Den Eeden | Nima C Emami | L. Kachuri | Nima C. Emami | Linda Kachuri | Travis J Meyers | Jun Shan
[1] Peter Kraft,et al. Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[2] J. Marchini,et al. Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.
[3] Alan M. Kwong,et al. Next-generation genotype imputation service and methods , 2016, Nature Genetics.
[4] P. Leung,et al. Cell Motility and Spreading Are Suppressed by HOXA4 in Ovarian Cancer Cells: Possible Involvement of β1 Integrin , 2008, Molecular Cancer Research.
[5] Zhiyong Lu,et al. tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine , 2018, Bioinform..
[6] P. Donnelly,et al. Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.
[7] John T. Wei,et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression , 2011, Nature Biotechnology.
[8] Ming Tang,et al. TumorFusions: an integrative resource for cancer-associated transcript fusions , 2017, Nucleic Acids Res..
[9] Peter Kraft,et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer , 2014, Nature Genetics.
[10] David Haussler,et al. The UCSC Genome Browser database: update 2010 , 2009, Nucleic Acids Res..
[11] Simon G. Coetzee,et al. Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci , 2014, PLoS genetics.
[12] Jeff S. Jasper,et al. ELF3 is a repressor of androgen receptor action in prostate cancer cells , 2014, Oncogene.
[13] Josyf Mychaleckyj,et al. Robust relationship inference in genome-wide association studies , 2010, Bioinform..
[14] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[15] Asha A. Nair,et al. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set , 2015, Nature Communications.
[16] S. Thibodeau,et al. Chromatin interactions and candidate genes at ten prostate cancer risk loci , 2016, Scientific Reports.
[17] Y. Hayashizaki,et al. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. , 2008, Biochemical and biophysical research communications.
[18] S. Natsugoe,et al. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA‐375 in pancreatic ductal adenocarcinoma , 2017, Cancer science.
[19] Stefan Nickels,et al. Haplotype reference consortium panel: Practical implications of imputations with large reference panels , 2017, Human mutation.
[20] Judy H. Cho,et al. Transcriptional Risk Scores link GWAS to eQTL and Predict Complications in Crohn's Disease , 2017, Nature Genetics.
[21] M. van Iterson,et al. Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution , 2016, Genome Biology.
[22] G. Coetzee,et al. 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus , 2016, Scientific Reports.
[23] Pui-Yan Kwok,et al. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer , 2017, Nature Communications.
[24] H. Zhang,et al. Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9 , 2012, Cancer Gene Therapy.
[25] M. Bollen,et al. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2 , 2007, Oncogene.
[26] Steven J. M. Jones,et al. The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.
[27] Terrence S. Furey,et al. The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..
[28] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[29] Thawfeek M. Varusai,et al. The Reactome Pathway Knowledgebase , 2017, Nucleic acids research.
[30] Martin Vingron,et al. Statistical Modeling of Transcription Factor Binding Affinities Predicts Regulatory Interactions , 2008, PLoS Comput. Biol..
[31] Hongshan Zhao,et al. Differential expression of MST4, STK25 and PDCD10 between benign prostatic hyperplasia and prostate cancer. , 2014, International journal of clinical and experimental pathology.
[32] Eurie L. Hong,et al. Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.
[33] J. Tchinda,et al. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.
[34] W. Hahn,et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis , 2012, Proceedings of the National Academy of Sciences.
[35] Kaanan P. Shah,et al. A gene-based association method for mapping traits using reference transcriptome data , 2015, Nature Genetics.
[36] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[37] Ye Ding,et al. Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells , 2015, Oncotarget.
[38] Mary Goldman,et al. The UCSC Cancer Genomics Browser: update 2015 , 2014, Nucleic Acids Res..
[39] Ramana V. Davuluri,et al. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer , 2016, Oncotarget.
[40] J. Lindberg,et al. Gene regulatory mechanisms underpinning prostate cancer susceptibility , 2016, Nature Genetics.
[41] R. Eeles,et al. Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. , 2008, The Journal of molecular diagnostics : JMD.
[42] M. Menon,et al. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. , 2007, Cancer research.
[43] Bartek Wilczynski,et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics , 2009, Bioinform..
[44] Alexander Gusev,et al. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions , 2018, Nature Communications.
[45] Xueying Mao,et al. The complexity of prostate cancer: genomic alterations and heterogeneity , 2012, Nature Reviews Urology.
[46] Alan M. Kwong,et al. A reference panel of 64,976 haplotypes for genotype imputation , 2015, Nature Genetics.
[47] Mary Goldman,et al. The UCSC cancer genomics browser: update 2011 , 2010, Nucleic Acids Res..
[48] S. Gabriel,et al. Assessing the impact of population stratification on genetic association studies , 2004, Nature Genetics.
[49] M. Clynes,et al. The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation , 2017, BMC Cancer.
[50] Sebastian M. Armasu,et al. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer , 2016, Oncotarget.
[51] M. Rubin,et al. TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] Mitchell J. Machiela,et al. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..
[53] Anushya Muruganujan,et al. PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements , 2016, Nucleic Acids Res..
[54] Robert Brown,et al. Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis , 2007, Clinical Cancer Research.
[55] C. Sabatti,et al. Characterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort , 2015, Genetics.
[56] P. Blackshear,et al. Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State , 2012, Cell.
[57] O. Delaneau,et al. A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.
[58] Nawaid Usmani,et al. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants , 2018, Nature Communications.
[59] Terrence S. Furey,et al. The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..
[60] Andrew R. Gehrke,et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo , 2010, The EMBO journal.
[61] Pui-Yan Kwok,et al. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. , 2015, Cancer discovery.
[62] Eleazar Eskin,et al. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. , 2011, American journal of human genetics.
[63] P. Eline Slagboom,et al. Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution , 2016, bioRxiv.
[64] A. Spurdle,et al. Kallikrein-Related Peptidase 3 (KLK3/PSA) Single Nucleotide Polymorphisms and Ovarian Cancer Survival , 2011, Twin Research and Human Genetics.
[65] C. Morrison,et al. High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy , 2014, The Prostate.
[66] Alan D. Lopez,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.
[67] Andrew Menzies,et al. Analysis of the Genetic Phylogeny of Multifocal Prostate Cancer Identifies Multiple Independent Clonal Expansions in Neoplastic and Morphologically Normal Prostate Tissue , 2015, Nature Genetics.
[68] Allison P. Heath,et al. Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.
[69] F. Claessens,et al. Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element. , 2013, Molecular endocrinology.
[70] Matthew L. Freedman,et al. Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis , 2010, PLoS genetics.
[71] L. Ashworth,et al. Molecular Cloning of the Human Kallikrein 15 Gene (KLK15) , 2001, The Journal of Biological Chemistry.
[72] Bin Yu,et al. Superheat: An R Package for Creating Beautiful and Extendable Heatmaps for Visualizing Complex Data , 2015, Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America.
[73] M. Loda,et al. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] Shane A. McCarthy,et al. Reference-based phasing using the Haplotype Reference Consortium panel , 2016, Nature Genetics.
[75] Brian L Browning,et al. Genotype Imputation with Millions of Reference Samples. , 2016, American journal of human genetics.
[76] Takafumi N. Yamaguchi,et al. TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer , 2017, Nature Genetics.
[77] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[78] Ting Wang,et al. The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions , 2017, Genome Biology.